Scientists want to create a production pipeline of a tomato crop enriched with the Parkinson's disease drug L-DOPA, giving patients new access to one of the world's most essential medicines.
The development of the genetically modified (GM) tomato, led by British researchers, has implications for developing nations where access to pharmaceutical drugs is restricted.
On the surface, this sounds like a good idea, but what about the people/children who eat these tomatoes for whom L-dopa would cause problems. Do we really want big corporations and big Pharma putting pharmaceuticals in our food? A better approach would be to force big Pharma to provide L-dopa therapy at a cost developing countries can afford.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.